Ian F. Smith - Dec 13, 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ David Tyronne Howton as attorney-in-fact for Ian F. Smith
Stock symbol
SLDB
Transactions as of
Dec 13, 2022
Transactions value $
$0
Form type
4
Date filed
12/15/2022, 05:15 PM
Previous filing
Dec 5, 2022
Next filing
Jan 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SLDB Common Stock 36.1K Dec 13, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Director Stock Option (Right to Buy) Award $0 +9.65K $0.00 9.65K Dec 13, 2022 Common Stock 9.65K $6.47 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amount reported has been adjusted to correct a mathematical error contained in the Form 4 filed by the Reporting Person on December 5, 2022.
F2 This option was granted on December 13, 2022 and vests in full on the one-year anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.